1h Free Analyst Time
The pregabalin market is poised to grow by $153.03 mn during 2022-2026, accelerating at a CAGR of 3.74% during the forecast period. The report on the pregabalin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the presence of a large patient pool related to neuropathic pain, an increasing geriatric population, and rising applications of pregabalin in various diseases.
The pregabalin market analysis includes the application segment and geographic landscape.
The pregabalin market is segmented as below:
By Application
- Neuropathic pain
- Epilepsy
- Anxiety disorders
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the pregabalin market covers the following areas:
- Pregabalin market sizing
- Pregabalin market forecast
- Pregabalin market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global pregabalin market: Biomax Biotechnics Pvt. Ltd., Camber Pharmaceuticals Inc., Cipla Ltd., Dr. Kumars Pharmaceuticals, Genesis Biotec Inc., H. L. Healthcare Pvt. Ltd., Lupin Ltd, Medley Pharmaceuticals Ltd., MK Medicine, MSN Laboratories, Neuracle Lifesciences Pvt. Ltd., Novartis AG, Pfizer Inc., Phoenix Biologicals Pvt. Ltd., Sun Pharmaceutical Industries Ltd, Swastik Life Sciences, Torrent Pharmaceuticals Ltd., and Vibcare Pharma Pvt. Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing focus on emerging economies.`
According to the report, one of the major drivers for this market is the presence of a large patient pool related to neuropathic pain.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Biomax Biotechnics Pvt. Ltd.
- Camber Pharmaceuticals Inc.
- Cipla Ltd.
- Dr. Kumars Pharmaceuticals
- Genesis Biotec Inc.
- H. L. Healthcare Pvt. Ltd.
- Lupin Ltd
- Medley Pharmaceuticals Ltd.
- MK Medicine
- MSN Laboratories
- Neuracle Lifesciences Pvt. Ltd.
- Novartis AG
- Pfizer Inc.
- Phoenix Biologicals Pvt. Ltd.
- Sun Pharmaceutical Industries Ltd
- Swastik Life Sciences
- Torrent Pharmaceuticals Ltd.
- Vibcare Pharma Pvt. Ltd.
